about
Novel Molecular Markers for Breast CancerCancer prevention: state of the art and future prospectsSafety and efficacy evaluation of pertuzumab in patients with solid tumorsPromoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis.Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.Correlation between LSP1 polymorphisms and the susceptibility to breast cancerExosomes in development, metastasis and drug resistance of breast cancer.Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.'Much clearer with pictures': using community-based participatory research to design and test a Picture Option Grid for underserved patients with breast cancer.p53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer.A lectin-based approach to detecting carcinogenesis in breast tissuemiR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study.Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells.Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte-Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System.siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration.Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.Niclosamide: Beyond an antihelminthic drug.Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines.EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys27 acetylation in the BIM gene promoter and enhancers.Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer.What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata.Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma.Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.Association of XPA polymorphism with breast cancer risk: A meta-analysis.Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysisSP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1
P2860
Q26753160-2BA920BD-85EB-4107-B8BF-1E46C2021ABBQ26770668-929528A6-13EF-4E1A-86E5-D1E92D97FA61Q33714388-1F5687F8-6BD2-41B5-8D9F-4907764FABEDQ35801560-11F25673-4D83-494C-B87F-F71DF156079BQ35846508-F6CF2E18-82A6-4B04-9802-8BB8523C6ED4Q35854410-0E9A7BA9-55F3-4954-8037-6C3B917473CDQ36016189-188BCB39-322D-43D0-854F-631352981C2EQ36088433-0C739A2D-D842-4D73-A2AC-EB91E70ABB9FQ36221605-B4EA615E-C538-46D8-919E-4482727E4028Q36252554-A14F76B3-7AF5-4F4B-9F51-3DBAD165D289Q36355992-539BA402-7326-4377-80C0-E5CCA391CF60Q36559566-632F6C5B-0606-4941-BD73-8F03C79C538CQ36688072-0B9C2DF6-8F95-4FA1-A31E-00198BB6DB83Q36954600-EBBA8A09-901F-48E8-A831-3C0F68E0D563Q37085995-68A75CB7-3363-4154-BE8E-13D086FFDD39Q37108676-90F4C97F-BCDD-4B55-8F13-289A0C8DA305Q37315252-2B45542C-58BC-4341-A752-13A95A0B35CBQ37392792-5D6ABCEF-9F52-4F8A-B792-36AF6DAD808FQ37607744-F5F269A5-DAD5-4E74-9308-771BBBC1B7C3Q37685419-386F9BCC-C9E2-4F73-BE3E-1601814F89A6Q37709334-E9BF1EA3-CF4E-4539-A494-D75218441431Q38629732-4901118F-C2BF-4718-8A71-0D63A4A1E7F0Q38724100-D181788F-6490-40DA-8697-9929B83B1014Q38837269-7DB103E6-07EC-4F91-9D61-E1A17A4FEE48Q39227540-AB2FA934-AD11-481E-B234-E00F135CFC9BQ41233971-8EA7490D-5736-4CAD-9000-01883C1EA6A4Q41701909-1FC8CB99-77CB-41F1-986D-784C121D84E4Q41858523-62BD773D-261F-494E-BB0D-5E81DD94D5E7Q41990150-772D9436-8E0C-461C-A3F7-863C716A8BFCQ43191053-A1C6A887-A186-4DAB-AA84-3E826A76015CQ48517621-B7F8FD2E-68A2-413A-B061-25010D995609Q49230144-D521F790-6E5E-4138-8360-56816D234375Q51583271-6ECFD2AE-9454-419A-880C-30A35879393AQ55270272-E370A89F-7C27-4197-9033-809CE4F135B8Q55691604-90381625-A7B7-415B-BE8E-B2ABA78AAEF6Q57110507-F4BEF33F-7A7B-4969-AE44-792496DE6556Q58696744-1233D1A0-8DBB-4887-B1A1-9107F8BC6E84Q58727524-E56E7783-E7F9-4ABF-8FCE-CD6E1AA8DDC4
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Breast cancer statistics and markers.
@ast
Breast cancer statistics and markers.
@en
Breast cancer statistics and markers.
@nl
type
label
Breast cancer statistics and markers.
@ast
Breast cancer statistics and markers.
@en
Breast cancer statistics and markers.
@nl
prefLabel
Breast cancer statistics and markers.
@ast
Breast cancer statistics and markers.
@en
Breast cancer statistics and markers.
@nl
P2093
P356
P1476
Breast cancer statistics and markers.
@en
P2093
Kasturi Kondapalli
Mallika Siva Donepudi
Pavithra Venkanteshan
Seelam Jeevan Amos
P304
P356
10.4103/0973-1482.137927
P407
P577
2014-07-01T00:00:00Z